Provided by Tiger Trade Technology Pte. Ltd.

Ashland

73.76
+0.05000.07%
Post-market: 73.760.00000.00%16:10 EDT
Volume:460.71K
Turnover:33.90M
Market Cap:3.38B
PE:64.19
High:74.01
Open:73.93
Low:72.45
Close:73.71
52wk High:78.25
52wk Low:46.30
Shares:45.76M
Float Shares:37.72M
Volume Ratio:0.99
T/O Rate:1.22%
Dividend:1.67
Dividend Rate:2.26%
EPS(TTM):1.15
EPS(LYR):-18.3696
ROE:3.99%
ROA:2.43%
PB:1.81
PE(LYR):-4.02

Loading ...

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

prnewswire
·
Mar 19

Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Dow Jones
·
Mar 19

Ashland CFO William Whitaker to join fireside chat at Gabelli Funds Specialty Chemicals Symposium

Reuters
·
Mar 18

Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets

Simply Wall St.
·
Mar 17

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 13

Molecular Partners Reports Highlights and Financial Results for Full Year 2025

GlobeNewswire
·
Mar 13

Press Release: Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026

Dow Jones
·
Mar 10

Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

GlobeNewswire
·
Mar 10

Press Release: Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 05

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 04

Press Release: Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 03

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Dow Jones
·
Feb 28

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Feb 27